Company page
Irlab Therapeutics Ab Class A
Irlab Therapeutics Ab Class A is a public company listed on the Swedish market under the ticker IRLAB_A. The company has a market capitalization of approximately 18.93 million USD. Irlab focuses on developing innovative treatments for neurological diseases.
- Ticker
- IRLAB_A:OMXSTO
- Asset type
- Stock
- Market cap
- $18.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK